TL;DR: A 2026 randomized clinical trial in JAMA Network Open found that one supervised 30 mg/70 kg psilocybin dose plus cognitive behavioral therapy produced 40.5% six-month smoking abstinence versus 10.0% with a nicotine patch plus the same therapy. Key Findings 40.5% vs. 10% prolonged abstinence at 6 months: 17 of 42 psilocybin participants stayed biochemically …
TL;DR: A 2026 randomized trial analysis in European Journal of Psychotraumatology found that COPE-A, an integrated exposure-based therapy for youth with posttraumatic stress disorder (PTSD) and substance use disorder (SUD), reduced PTSD symptoms more than supportive counseling, but substance-use reductions were not significantly stronger than counseling. Key Findings 49 treated participants were analyzed: Youth aged …
TL;DR: A 2026 medRxiv preprint found that hospital stakeholders saw a need for CARES, a Comprehensive Addiction Risk Evaluation System combining genetic and behavioral/environmental risk information, but warned that provider burden, substance-use stigma, and workflow integration could limit adoption. Key Findings 15 stakeholder interviews: Researchers conducted semi-structured interviews using the Consolidated Framework for Implementation Research. …
TL;DR: A 2025 systematic review in Translational Psychiatry found that substance use disorder was associated with recurring resting-state functional MRI (rs-fMRI), a scan of spontaneous brain-network communication, abnormalities in reward and self-control circuits across 53 studies. Key Findings 53-study meta-analysis: Researchers pooled whole-brain rs-fMRI studies covering 1,700 people with substance use disorder and 1,792 healthy …
Cannabinoids Had Weak Evidence for Mental Disorders TL;DR: A Lancet Psychiatry review of randomized trials found little support for routine cannabinoid treatment in common mental disorders, despite possible weak signals in a few narrower conditions. Key Findings 54 randomized controlled trials were reviewed: The analysis covered 2,477 participants across mental disorders and substance-use disorders. Routine …
